SCHEMBL10135382

SCHEMBL10135382

Cc1cc2oc3cc(O)c(C)cc3c2c(=O)o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
MAPT P10636 3/20 0.60
ANTXR2 P58335 1/20 0.49
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
NT5E P21589 2/20 0.44
CLK2 P49760 1/20 0.44
MAOA P21397 4/20 0.44
CYP3A4 P08684 3/20 0.44
MCL1 Q07820 3/20 0.44
THRB P10828 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 1/20 0.44
AKR1B1 P15121 1/20 0.44
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RECQL P46063 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL580862 0.90 KDM4E (0.64) KDM4EMEN1KMT2AMAPTANTXR2
SCHEMBL10181612 0.82 KDM4E (0.55) KDM4EMEN1KMT2AMAPTANTXR2
SCHEMBL10181447 0.77 PTGS1 (0.65) KDM4EMEN1KMT2AMAPTANTXR2
SCHEMBL10135387 0.77 KDM4E (0.50) KDM4EMEN1KMT2AMAPTANTXR2
SCHEMBL10135394 0.77 ELANE (0.46) MAPTTHRBALDH1A1SMN1; SMN2GAA
SCHEMBL10135386 0.76 KDM4E (0.50) KDM4EMEN1KMT2AMAPTANTXR2
SCHEMBL10135395 0.76 ELANE (0.48) KDM4EMAPTTHRBALDH1A1SMN1; SMN2
SCHEMBL10135414 0.76 NT5E (0.37) KDM4EMEN1KMT2AMAPTPTGS1
SCHEMBL10182556 0.75 NUAK1 (0.56) KDM4EMEN1KMT2AMAPTANTXR2
SCHEMBL10135385 0.75 MAOA (0.54) KDM4EMEN1KMT2AMAPTANTXR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859235-B2 Methods in cell cultures, and related inventions, employing certain additives BASF SE (DE) 2014-10-14 US disclosed
US-8383088-B2 Coumestan-like antioxidants and UV absorbants BASF SE (DE) 2013-02-26 US disclosed
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BASF SE (DE) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BBOX1, NEFM, NQO1 KDM4E 715/4885MEN1 3694/4885KMT2A 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.